Clinical impact of the worldwide shortage of verteporfin (Visudyne®) on ophthalmic care
Sign Up to like & getrecommendations! Published in 2022 at "Acta Ophthalmologica"
DOI: 10.1111/aos.15148
Abstract: Since July 2021, a worldwide shortage of verteporfin (Visudyne®) occurred: an essential medicine required for photodynamic therapy (PDT). PDT with verteporfin has a broad range of indications in ophthalmology, including chronic central serous chorioretinopathy, polypoidal… read more here.
Keywords: verteporfin visudyne; shortage verteporfin; verteporfin; worldwide shortage ... See more keywords